16
Mon
March
Biotech Insights & Analysis
Expert analysis, guides, and insights on biotech drug development, FDA approvals, and investment strategies.
How does FDA drug application process work
An overview of the FDA’s role in drug and biologic regulation, the NDA and BLA approval pathways, and why FDA review timelines and decisions are critical to biotech companies and investors.
Read Article →
Patent Cliff: Key Indicators Investors Should Track Before Loss of Exclusivity
An overview of the pharmaceutical patent cliff and the key indicators to monitor as loss of exclusivity drives generic and biosimilar competition and accelerates revenue erosion.
Read Article →
Why Some FDA Approvals Trigger Stock Drops Instead of Gains
An analysis of why biotech stocks sometimes fall after FDA approval due to market expectations and valuation dynamics.
Read Article →
The Impact of Macroeconomic Data on Biotech Stocks: Interest Rates, GDP, and Global Capital Flows
A concise analysis of how interest rates, inflation, and macroeconomic trends affect biotech stock valuations.
Read Article →
Why Biotech Stocks Are So Volatile
An explanation of the key factors driving extreme volatility in biotech stocks, including clinical trials, FDA decisions, and funding risk.
Read Article →